Establishment and Characterization of Acquired Resistance to Platinum Anticancer Drugs in Human Ovarian Carcinoma Cells

To investigate differences in resistance to cis‐diamminedichloroplatinum(II) (CDDP) and diammine (1,1‐cyclobutanecarboxylato)platinum(II) (CBDCA), and their newly developed derivative, ((—)‐(R)‐2‐aminomethylpyrrolidine (1,1‐cyclobutanedicarboxylato)platinum (II)) (DWA2114R), four types of resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Misawa, Toshiya, Kikkawa, Fumitaka, Maeda, Osamu, Obata, Naoko H., Higashide, Koji, Suganuma, Nobuhiko, Tomoda, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920572/
https://www.ncbi.nlm.nih.gov/pubmed/7737915
http://dx.doi.org/10.1111/j.1349-7006.1995.tb02992.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920572/
https://www.ncbi.nlm.nih.gov/pubmed/7737915
http://dx.doi.org/10.1111/j.1349-7006.1995.tb02992.x

Ejemplares similares